Credits Available: 7.25 AMA PRA Category 1 Credit™, ABIM MOC

Description: This course offers a comprehensive update on the diagnosis and management of chronic spontaneous urticaria (CSU), a burdensome skin condition marked by recurrent hives and/or angioedema. Participants will explore evidence-based diagnostic approaches that reduce unnecessary testing, examine the clinical relevance of CSU endotypes and biomarkers, and apply guideline-based treatment algorithms. The course also highlights the evolving therapeutic landscape—including BTK inhibitors, IL-4/IL-13 inhibitors, and mast cell–targeted therapies—with emphasis on mechanism of action, clinical trial data, safety, and patient selection. Designed for allergists, dermatologists, and pediatric dermatologists, seeking to improve diagnostic accuracy, personalizing treatment, and effectively integrating emerging therapies into practice.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Allergy and Immunology, Dermatology, Pediatric Dermatology

Miguel Wolbert

West Texas Allergy
Chief Medical Officer

I am double Board Certified in Allergy/Immunology and Pediatrics from the University of Michigan. I have been the medical director at West Texas Allergy since 2010, and I am the current president of the Texas Allergy, Asthma, and Immune Society.